Vis enkel innførsel

dc.contributor.authorUldahl, Svein Atleeng
dc.date.accessioned2006-07-07T08:07:18Z
dc.date.available2006-07-07T08:07:18Z
dc.date.issued2006eng
dc.identifier.urihttp://hdl.handle.net/1956/1511
dc.description.abstractMicroalgae and cyanobacteria has trough the last couple of decades been increasingly recognized as a valuable source of a variety of bioactive compounds. Many species have been investigated, but these represent mostly strains from tropic or subtropical areas. Norway has, with its long coastline, access to both temperate and polar waters, and thus a unique opportunity to prospect for marine organisms that might possess novel cold-water adapted properties. Screening for bioactivity is commonly performed in vivo in a bioassay purposefully designed for revealing a defined bioactivity (e.g. fungicide or antibacterial activity). This allows the testing of many crude extracts. The search for new drugs against fungal infections is a major challenge to current research in mycotic diseases. In this Thesis a new method (bioassay) targeting spore swelling and germination to assess antifungal susceptibility is developed and evaluated. Traditionally, antifungal activity has been investigated using disk diffusion assays or micro-well plates. Inhibition is measured as a function of radial growth, inhibition zone or turbidity. Construction of a bioassay composed of germinating fungal spores bears the prospect of being a more rapid method, allowing more extracts to be screened within a shorter time frame. It also can be used to reveal antifungal action at an early state in the prospecting by the mode of its action on the spores. A strain of Absidia glauca Hagem served as model organism. A Beckman Coulter Multizisertm 3 particle analyser was applied for the determination of bioactivity and investigation of the sporangiospores. Effects of crude extracts from different microalgae were investigated as changes in volumes of, or as a decreased germination rate rather than percentage of germinating spores. 21 microalgae (15 different marine Chlorophytes, 5 selected Artic and Antarctic terrestrial Cyanobacteria, and 1 additional Chlorophyte isolate of unknown origin) were cultivated for the production of biomass, harvested and extracted (hydrophilic and lipophilic extracts), and screened for antifungal activity. Among these a strain of Phormidium sp. (NIVA 209) proved to be an interesting candidate for fungicide effects. Several hydrophilic extracts improved germination rates. The method was concluded to be a suitable contender for the detection of bioactivities. These results supports that suppression of spore swelling provides early indication of preservative potential and the type of swelling curve produced indicates the mechanism of fungistasis.en_US
dc.format.extent1752426 byteseng
dc.format.mimetypeapplication/pdfeng
dc.language.isoengeng
dc.publisherThe University of Bergenen_US
dc.titleMicroalgal Bioprospecting. Spore swelling and germination as a bioassay for the rapid screening of crude algal extracts for antifungal activityen_US
dc.typeMaster thesis
dc.rights.holderThe authoren_US
dc.rights.holderCopyright the author. All rights reserveden_US
dc.subject.nsiVDP::Matematikk og Naturvitenskap: 400::Zoologiske og botaniske fag: 480::Plantefysiologi: 492nob


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel